Progesterone belongs to the steroid hormone class and exerts its biological effects through high-affinity binding to specific nuclear receptor subtypes that act as ligand-activated transcription factors upon steroid occupancy. Receptor-ligand complex formation triggers dimerisation, nuclear translocation, and sequence-specific DNA binding at hormone response elements, modulating the transcription of gene networks that control critical physiological homeostasis mechanisms.
The intraspecies uncertainty factor F2 for Progesterone covers the range of pharmacokinetic and pharmacodynamic variability within the human population, ensuring the derived PDE is protective for sensitive subgroups including paediatric patients with immature CYP450 activity, elderly patients with reduced hepatic and renal clearance, patients with
